Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)

PHASE3CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Peripheral Vascular DiseasesIntermittent Claudication
Interventions
DRUG

Propionyl-L-Carnitine

2 grams per day for six months

DRUG

PLC

2 grams/day for six months

Trial Locations (9)

14618

University of Rochester Medical Center, Rochester

27705

Durham VA Medical Center, Durham

28803

Asheville Cardiology Associates, Asheville

32216

Jacksonville Center for Clinical Research, Jacksonville

32501

Baptist Clinical Research, Pensacola

60525

Western Suburban Cardiologists, Ltd., LaGrange

62702

SIU School of Medicine, Springfield

01655

University of Massachusetts Medical Center, Worchester

03756

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

Colorado Prevention Center

OTHER

lead

Sigma-Tau Research, Inc.

INDUSTRY

NCT00399919 - Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication) | Biotech Hunter | Biotech Hunter